SEC Comment Letter for BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149) (BIVI) — Jun 22, 2016
BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149)
Date: June 22, 2016 · CIK: 0001580149 · Accession: 0000000000-16-081514
AI Filing Summary & Sentiment
Letter
Mail Stop 4720 June 22 , 2016 Jonathan M. Adams Chief Executive Officer NanoAntibiotics, Inc. 100 Cummings Center, Suite 247 -C Beverly, MA 01915 USA
Re: NanoAntibiotics, Inc. Preliminary Proxy Statement on Schedule 14A Filed June 8, 2016 File No. 000 -55292
Dear Mr. Adams:
We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We u rge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
Mail Stop 4720 June 22 , 2016 Jonathan M. Adams Chief Executive Officer NanoAntibiotics, Inc. 100 Cummings Center, Suite 247 -C Beverly, MA 01915 USA Re: NanoAntibiotics, Inc. Preliminary Proxy Statement on Schedule 14A Filed June 8, 2016 File No. 000 -55292 Dear Mr. Adams: We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We u rge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Mary Beth Breslin for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Peter Campitiello Kane Kessler, P.C.